AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteFidaxomicin is the major analogue of a family of macrocyclic lactones isolated independently by three different groups from cultures belonging to three different genera (Actinoplanes, Dactylosporangium and Micromonospora) known as lipiarmycin A3, tiacumicin B and clostomicin B1, respectively. Fidaxomicin is a narrow spectrum antibiotic with excellent activity against Gram positive bacteria, notably Clostridium difficile. Fidaxomicin […]
More Information Supplier PageFidaxomicin is the major analogue of a family of macrocyclic lactones isolated independently by three different groups from cultures belonging to three different genera (Actinoplanes, Dactylosporangium and Micromonospora) known as lipiarmycin A3, tiacumicin B and clostomicin B1, respectively. Fidaxomicin is a narrow spectrum antibiotic with excellent activity against Gram positive bacteria, notably Clostridium difficile. Fidaxomicin […]
More Information Supplier PageBMS-790052 is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM.
More Information Supplier PageBMS-790052 is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM.
More Information Supplier PageBMS-790052 is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM.
More Information Supplier PageFilgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
More Information Supplier PageFilgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
More Information Supplier PageFilgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
More Information Supplier PageFilgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
More Information Supplier PageFilixic acid ABA was extracted from driedopteris crassirhizoma Nakai. Rhizome.
More Information Supplier PageFilixic acid ABA was extracted from driedopteris crassirhizoma Nakai. Rhizome.
More Information Supplier PageFilixic acid ABA was extracted from driedopteris crassirhizoma Nakai. Rhizome.
More Information Supplier PageFinasteride is a synthetic type II 5??-reductase inhibitor. This enzyme converts testosterone to dihydrotestosterone (DHT).
More Information Supplier PageFinasteride is a synthetic type II 5??-reductase inhibitor. This enzyme converts testosterone to dihydrotestosterone (DHT).
More Information Supplier PageFinasteride is a synthetic type II 5??-reductase inhibitor. This enzyme converts testosterone to dihydrotestosterone (DHT).
More Information Supplier PageFinasteride is a synthetic type II 5??-reductase inhibitor. This enzyme converts testosterone to dihydrotestosterone (DHT).
More Information Supplier PageIsoforms of phospholipase D (PLD) cleave the head group from phospholipids, releasing the second messenger phosphatidic acid (PA), which can produce changes in Ras activation, cell spreading, stress fiber formation, chemotaxis, and membrane vesicle trafficking. FIPI is a derivative of halopemide which potently inhibits both PLD1 (IC50 = 25 nM) and PLD2 (IC50 = 20 […]
More Information Supplier PageIsoforms of phospholipase D (PLD) cleave the head group from phospholipids, releasing the second messenger phosphatidic acid (PA), which can produce changes in Ras activation, cell spreading, stress fiber formation, chemotaxis, and membrane vesicle trafficking. FIPI is a derivative of halopemide which potently inhibits both PLD1 (IC50 = 25 nM) and PLD2 (IC50 = 20 […]
More Information Supplier PageIsoforms of phospholipase D (PLD) cleave the head group from phospholipids, releasing the second messenger phosphatidic acid (PA), which can produce changes in Ras activation, cell spreading, stress fiber formation, chemotaxis, and membrane vesicle trafficking. FIPI is a derivative of halopemide which potently inhibits both PLD1 (IC50 = 25 nM) and PLD2 (IC50 = 20 […]
More Information Supplier PageFirategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).
More Information Supplier PageFirategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).
More Information Supplier PageFirategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).
More Information Supplier PageFirategrast is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS).
More Information Supplier PageFisetin is a flavonol, a structurally distinct chemical substance that belongs to the flavonoid group of polyphenols. It can be found in many plants, where it serves as a colouring agent. Possible anti-aging, anti-inflammatory, anti-cancer, and anti-viral properties of fisetin are under active scientific investigation.
More Information Supplier PageFisetin is a flavonol, a structurally distinct chemical substance that belongs to the flavonoid group of polyphenols. It can be found in many plants, where it serves as a colouring agent. Possible anti-aging, anti-inflammatory, anti-cancer, and anti-viral properties of fisetin are under active scientific investigation.
More Information Supplier PageFisetin is a flavonol, a structurally distinct chemical substance that belongs to the flavonoid group of polyphenols. It can be found in many plants, where it serves as a colouring agent. Possible anti-aging, anti-inflammatory, anti-cancer, and anti-viral properties of fisetin are under active scientific investigation.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK3311 is a cell-permeable and orally available sulfonanilide that acts as a selective Cox-2 inhibitor and NSAID.
More Information Supplier PageFK-506 is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient’s immune system and so lower the risk of organ rejection. It reduces interleukin-2 (IL-2) production by T-cells.
More Information Supplier PageFK-506 is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient’s immune system and so lower the risk of organ rejection. It reduces interleukin-2 (IL-2) production by T-cells.
More Information Supplier PageFK-506 is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient’s immune system and so lower the risk of organ rejection. It reduces interleukin-2 (IL-2) production by T-cells.
More Information Supplier PageFK-506 is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient’s immune system and so lower the risk of organ rejection. It reduces interleukin-2 (IL-2) production by T-cells.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
More Information Supplier PageFLAG tag Peptide is a 8 amino acid peptide with an enterokinase-cleavage site used for the purification of recombinant proteins.
More Information Supplier PageFLAG tag Peptide is a 8 amino acid peptide with an enterokinase-cleavage site used for the purification of recombinant proteins.
More Information Supplier PageFLAG tag Peptide is a 8 amino acid peptide with an enterokinase-cleavage site used for the purification of recombinant proteins.
More Information Supplier PageFlavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
More Information Supplier PageFlavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
More Information Supplier PageFlavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
More Information Supplier PageFlavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
More Information Supplier PageFlavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia.
More Information Supplier PageFlavopiridol HCl is an inhibitor of cyclin-dependent kinases. The (-)-cis form induces apoptosis in particular tumor cells.
More Information Supplier PageFlavopiridol HCl is an inhibitor of cyclin-dependent kinases. The (-)-cis form induces apoptosis in particular tumor cells.
More Information Supplier Page
